Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease

Autor: Garcia-Miralles, Marta, Ooi, Jolene, Ferrari Bardile, Costanza, Tan, Liang Juin, George, Maya, Drum, Chester L., Lin, Rachel Yanping, Hayden, Michael R., Pouladi, Mahmoud A.
Zdroj: In Experimental Neurology April 2016 278:4-10
Databáze: ScienceDirect
Externí odkaz: